00951nam0-22002891i-450-99000415278040332120080215091615.0000415278FED01000415278(Aleph)000415278FED0100041527819990604d1975----km-y0itay50------baitay-------00-y-<<Il >>bambino non vistoUna esperienza di formazione degli educatori per una nuova scuola dell'infanziaa cura del Dipartimento dei servizi sociali del Comune di Folignointroduzione di Alberto AlbertiRomaEditorri Riuniti1975166 p.19 cmPaideia44Alberti,AlbertoFOLIGNODipartimento de i servizi socialiITUNINARICAUNIMARCBK990004152780403321P.1 DID 17I.P.89FLFBCFLFBCBambino non visto474925UNINA04521nam 2201021z- 450 991058021390332120220706(CKB)5690000000011949(oapen)https://directory.doabooks.org/handle/20.500.12854/87533(oapen)doab87533(EXLCZ)99569000000001194920202207d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNeurotransmitter-Related Molecular Modeling StudiesBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (188 p.)3-0365-4277-9 3-0365-4278-7 This book focuses of the neurotransmission phenomenon. By definition, neurotransmitters are chemicals that enable communication, i.e., the flow of nerve impulses between nerve cells or between nerve cells and muscles and glands. Recently, one can distinguish excitatory and inhibitory mediators, both of which are endo-exogenous compounds that control the function of the whole organism. From a chemical point of view, neurotransmitters belong to many different structural groups, such as amino acids (such as glycine), peptides (such as substance P, somatostatin), monoamines (such as noradrenaline or dopamine), purine derivatives (such as adenosine), gases (such as nitrogen, NO, carbon monoxide CO), and acetylcholine. From a medical point of view, disturbances in the concentration of neurotransmitters in the body result in the occurrence of mental disorders and diseases (such as depression, schizophrenia, Parkinson's disease) and contribute to the occurrence of dementia (including Alzheimer's disease), among other diseases. However, the problem is much wider. These disorders can lead to a number of cardiovascular diseases and can lead to the development of vascular diseases of the brain as well as in many other organs. Therefore, pharmacological intervention is a therapy that tries to interfere with regulatory processes year after year. Such treatments improve survival, reduce the frequency of readmission, and improve patients' quality of life.ChemistrybicsscResearch & information: generalbicssc3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors5-HT receptorsacetylcholineadverse drug reactionandrogenetic alopeciaantibioticsatheroprotectionBDNFcardiac voltage-gated ion channelschronic heart failure (CHF)cognitive impairmentdementiadepressiondopaminedysautonomiaECG studygastrointestinal tractgenetic polymorphismsglutamateguanylate cyclase (GC)halogenated pyrazolinesinflammationkineticslevodopamixed dyslipidemiamolecular dynamicsmolecular modelingmonoamine oxidase inhibitorsmousemTORneurodegenerative diseasesneuroprotectionneurotoxicityneurotransmissionneurotransmittersorthostatic hypotensionoxidative stresspulmonary arterial hypertension (PAH)renin-angiotensin systemreserpine-induced fibromyalgia modelreversibilityrisk factorsropiniroleserotoninserotonin and dopamine in fibromyalgiaSGLT2isodium-glucose cotransporter 2 inhibitorsstatinsstroketiagabinetype 2 diabetes mellitusvortioxetinewhite matter hyperintensitiesChemistryResearch & information: generalNowaczyk Alicjaedt1332311Grześk GrzegorzedtNowaczyk AlicjaothGrześk GrzegorzothBOOK9910580213903321Neurotransmitter-Related Molecular Modeling Studies3040814UNINA